Correspondence to Dr Philippe Pibarot, Cardiology, Quebec Heart and Lung Institute, Quebec City, QC G1V 4G5, Canada; philippe.pibarot{at}med.ulaval.ca To be aware of the prevalence, pathophysiology ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...
Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...
5 Novo Nordisk Research Centre Oxford, Old Road Campus, Oxford, UK Objective Identify whether participants with lower education are less likely to report taking statins for primary cardiovascular ...
Background Although the prognostic implications of severe mitral regurgitation (MR) are well recognised, they are less clear ...
Correspondence to Dr Simrat Gill, Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK; s.gill.5{at}bham.ac.uk Objectives Timely diagnosis of atrial fibrillation (AF) is ...
Correspondence to Dr Thomas Joseph Ford, BHF Cardiovascular Research Centre, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow G128QQ, UK; tom.ford{at}health.nsw.gov.au ...
Correspondence to Dr Rohan S Wijesurendra, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK; rohan.wijesurendra{at}cardiov.ox.ac.uk; Professor Barbara Casadei, Division of ...
8 F-CRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, Vandoeuvre-les-Nancy, France Objective It is not fully understood whether and how socioeconomic status (SES) has a prognostic impact in ...
Objective Myocardial ischaemia is a leading cause of acute heart failure (AHF). However, optimal revascularisation strategies in AHF are unclear. We aimed to compare two revascularisation strategies, ...
Objective Examine the effect of tamoxifen and aromatase inhibitors (AIs) on the risk of 12 clinically relevant cardiovascular outcomes in postmenopausal female breast cancer survivors. Methods We ...